Expression of IL-18 by Mycobacterium avium-infected human monocytes; association with M. avium virulence

H Shiratsuchi1, J J Ellner

  • 1Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4984, USA. hxs4@po.cwru.edu

Insights

Disseminated Mycobacterium avium infection, common in advanced AIDS, involves interferon-gamma (IFN-gamma). This study shows avirulent M. avium strains induce higher IL-18 and IFN-gamma, suggesting IL-18

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Disseminated Mycobacterium avium infection is a frequent bacterial infection in advanced AIDS patients.
  • Interferon-gamma (IFN-gamma) is crucial for host defense against M. avium.
  • Interleukin-18 (IL-18) is a potent inducer of IFN-gamma.

Purpose of the Study:

  • To examine the expression of IL-18 and IFN-gamma in human monocytes after M. avium infection.
  • To investigate the role of IL-18 in modulating M. avium pathogenicity and host defense.

Main Methods:

  • Human monocytes were co-cultured with virulent (SmT) and avirulent (SmD) M. avium strains.
  • IL-18 and IFN-gamma concentrations in culture supernatants were measured.
  • IL-18 mRNA and protein expression were analyzed using RT-PCR and Western blotting.
  • The effect of recombinant IL-12 and IL-18 on M. avium-induced IFN-gamma production was assessed.

Main Results:

  • The avirulent SmD strain induced significantly higher IL-18 and IFN-gamma levels compared to the virulent SmT strain.
  • IFN-gamma production was partially inhibited by anti-human IL-18 monoclonal antibodies.
  • Both recombinant IL-12 and IL-18 augmented M. avium-induced IFN-gamma production.
  • IL-18 mRNA expression peaked at 3-6 hours post-infection, and IL-18 protein was detected within 1 hour.

Conclusions:

  • Higher IL-18 expression by monocytes infected with the avirulent M. avium strain may lead to increased IFN-gamma production, influencing pathogenicity.
  • Local induction of IL-18 appears critical for both M. avium pathogenicity and host defense.
  • IL-18 represents a potential candidate for immunotherapy against M. avium infections.